Please wait while we open this resource.
K
Clinical reviews
RANDOMIZED, CONTROLLED CLINICAL TRIAL OF THE DIALIVE LIVER DIALYSIS DEVICE VERSUS STANDARD OF CARE IN PATIENTS WITH ACUTE ON-CHRONIC LIVER FAILURE
Journal of Hepatology
PDF202334 pages1.7 MB
Acute-on-chronic liver failure (ACLF) is a severe condition characterized by systemic inflammation and high mortality rates. The DIALIVE device aims to improve treatment outcomes by exchanging dysfunctional albumin and removing harmful substances from the blood. This study evaluates the device's safety, performance, and effects on relevant biomarkers in patients suffering from ACLF.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Hepatitis E Virus, Second Edition (Springer, 2023)
Same clinical topic · Hepatology
AUTOIMMUNE HEPATITIS
Same clinical topic · Hepatology
MOLECULAR MECHANISMS AND PATHOGENESIS OF MASH
Same clinical topic · Hepatology
CIRRHOSIS, PORTAL HYPERTENSION AND HEPATOCELLULAR CARCINOMA: A STAGE-BASED APPROACH
Same clinical topic · Hepatology
NEW APPROACHES TO CHRONIC HEPATITIS B
Same clinical topic · Hepatology
CURRENT THERAPEUTIC LANDSCAPE AND FUTURE TREATMENT PERSPECTIVES OF MASH
Same clinical topic · Hepatology
Intravenous albumin after outpatient paracentesis reduces the risk of AKI hospitalization: A national cohort study
Same clinical topic · Hepatology
LIVER TRANSPLANTATION FOR PATIENTS WITH SEVERE ACUTE ON CHRONIC LIVER FAILURE: IT IS TIME TO CHANGE PARADIGMS
Same clinical topic · Hepatology
HEPATITIS B
Same clinical topic · Hepatology